CDH1 and cancer: To validate the accuracy of our strategy, cells expressing wild-type (WT) E-cadherin and a panel of cancer-related E-cadherin mutants, leading to aberrant E-cadherin expression and impacting adhesion competence were used16, 19, 20, 21, 22, 23, 24, 25.